Orion enters supply agreement with Peptonic Medical

The contract manufacturing organisation has made a commercial supply agreement for the manufacture and packaging of VagiVital

Global contract manufacturing organisation, Orion Contract Manufacturing, has signed a commercial supply agreement with Peptonic Medical for the manufacture and packaging of its patented product, VagiVital.

The OTC product is used to treat vaginal atrophy and dryness and is due to launch later this year.

Following the successful transfer of the product’s manufacturing technology, Orion Contract Manufacturing, based in Espoo, Finland, will be responsible for the launch and ongoing supply of the product to multiple markets.

Esa Nauska, head of Orion Contract Manufacturing, said: “We have more than a decade of experience working with gels and solutions similar to VagiVital. Our knowledge of manufacturing semi-solid products of this nature made us an ideal candidate for this project.”

“Our versatility manufacturing and packaging expertise also mean that we can scale the formulation up to commercial production while meeting multiple market requirements. We are looking forward to what will hopefully be a long and mutually beneficial partnership with Peptonic Medical.”

Johan Inborr, CEO of Peptonic Medical said: “Orion has met all our expectations during our collaboration so far ensuring successful technology transfer to enable the rest of the project. The OTC product is used to treat vaginal atrophy and dryness and is due to launch later this year.”

“We have great confidence in its manufacturing and packaging capabilities and are excited to work together to bring our product to market. We’re very much looking forward to developing a long-lasting partnership with Orion.”

Companies